EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

This list contains a non-exhaustive inventory of substances that fall within the scope of the European Union's definition of hazardous chemical and biological substances, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; and (2) Annex III of Directive 2000/54/EC (Biological Agents). The EU's Occupational Safety and Health (OSH) Framework Directive 89/391/EEC applies to risks arising from chemical, physical and biological agents at the workplace.

Last updated 02 May 2024. Database contains 4691 unique substances/entries.

Filter the list

Showing 1,701 - 1,800 of 4,691 results.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)
nickel disilicide	235-379-3	12201-89-7	Carc. 1A; STOT RE 1; Skin Sens. 1
nickel dithiocyanate	237-205-1	13689-92-4	Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
nickel hydrogen phosphate	238-278-2	14332-34-4	Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
nickel hydroxide	234-348-1	11113-74-9	Carc. 1A; Repr. 1B; Muta. 2; STOT RE 1; Acute Tox. 4; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
nickel monoxide	215-215-7	1313-99-1	Carc. 1A; STOT RE 1; Skin Sens. 1
nickel oxide	234-323-5	11099-02-8	Carc. 1A; STOT RE 1; Skin Sens. 1
nickel potassium fluoride	-	11132-10-8	Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
nickel selenate	239-125-2	15060-62-5	Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
nickel selenide	215-216-2	1314-05-2	Carc. 1A; STOT RE 1; Skin Sens. 1
nickel sulfide	234-349-7	11113-75-0	Carc. 1A; Muta. 2; STOT RE 1; Skin Sens. 1
nickel telluride	235-260-6	12142-88-0	Carc. 1A; STOT RE 1; Skin Sens. 1
nickel tellurium tetraoxide	239-974-9	15852-21-8	Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
nickel tellurium trioxide	239-967-0	15851-52-2	Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
nickel tin trioxide; nickel stannate	234-824-9	12035-38-0	Carc. 1A; STOT RE 1; Skin Sens. 1
nickel titanium oxide	235-752-0	12653-76-8	Carc. 1A; STOT RE 1; Skin Sens. 1
nickel titanium trioxide	234-825-4	12035-39-1	Carc. 1A; STOT RE 1; Skin Sens. 1
nickel triuranium decaoxide	239-876-6	15780-33-3	Carc. 1A; STOT RE 1; Skin Sens. 1
nickel tungsten tetraoxide	238-032-4	14177-51-6	Carc. 1A; STOT RE 1; Skin Sens. 1
nickel(II) hydrogen citrate	242-533-3	18721-51-2	Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
nickel(II) palmitate	237-138-8	13654-40-5	Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
nickel(II) selenite	233-263-7	10101-96-9	Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
nickel(II) trifluoroacetate	240-235-8	16083-14-0	Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
nitrapyrin (ISO); 2-chloro-6-trichloromethylpyridine	217-682-2	1929-82-4	Acute Tox. 4
nitric acid, nickel salt	238-076-4	14216-75-2	Ox. Sol. 2; Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1
nitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate DABCO X-412	413-670-8	103969-79-5	Eye Irrit. 2; Skin Sens. 1
nitrofen (ISO); 2,4-dichlorophenyl 4-nitrophenyl ether	217-406-0	1836-75-5	Carc. 1B; Repr. 1B; Acute Tox. 4
nitrogen dioxide	233-272-6	10102-44-0	Press. Gas; Ox. Gas 1; Acute Tox. 2; Skin Corr. 1B
nonanoic acid	203-931-2	112-05-0	Skin Irrit. 2; Eye Irrit. 2
N—tert-pentyl-2-benzothiazolesulfenamide VULKANISATIONSBESCHLEUNIGER VP KA 9124	404-380-2	110799-28-5	Skin Sens. 1
O, O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime] ASIL-322; OS-5200	421-870-1	156145-66-3	Repr. 2; Acute Tox. 4; STOT RE 2
O, O-tert-butyl O-docosyl monoperoxyoxalate KENODOX	404-300-6	116753-76-5	Org. Perox. C
O-hexyl-N-ethoxycarbonylthiocarbamate	432-750-3	109202-58-6	Carc. 1B; Muta. 1B; Acute Tox. 4; STOT RE 2; Skin Sens. 1
O-isobutyl-N-ethoxy carbonylthiocarbamate	434-350-4	103122-66-3	Flam. Liq. 3; Carc. 1B; Muta. 1B; Acute Tox. 4; STOT RE 2; Skin Sens. 1
octadecylamine	204-695-3	124-30-1	Asp. Tox. 1; STOT RE 2; Skin Irrit. 2; Eye Dam. 1
octane; n-octane	203-892-1	111-65-9	Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3
octanoic acid	204-677-5	124-07-2	Skin Corr. 1C
octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate PROCION BRILLIANT ORANGE H-EXL; S156745	412-960-1	148878-21-1	Eye Dam. 1; Skin Sens. 1
octyl 3,4,5-trihydroxybenzoate	213-853-0	1034-01-1	Acute Tox. 4; Skin Sens. 1
omethoate (ISO); O, O-dimethyl S-methylcarbamoylmethyl phosphorothioate	214-197-8	1113-02-6	Acute Tox. 3; Acute Tox. 4
orthoboric acid, sodium salt	237-560-2	13840-56-7	Repr. 1B
oxalic acid	205-634-3	144-62-7	Acute Tox. 4
oxasulfuron (ISO); oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate	604-430-5	144651-06-9	STOT RE 2
oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide LUCHEM HA-R 100; LUPERSOL HA-R 100	413-230-5	122035-71-6	Eye Dam. 1; Skin Sens. 1
oxydiethylene bis(chloroformate)	203-430-9	106-75-2	Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1
p-anisidine; 4-methoxyaniline	203-254-2	104-94-9	Acute Tox. 2; Acute Tox. 1; STOT RE 2
p-benzoquinone; quinone	203-405-2	106-51-4	Acute Tox. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
p-cresol	203-398-6	106-44-5	Acute Tox. 3; Skin Corr. 1B
p-nitroaniline	202-810-1	100-01-6	Acute Tox. 3; STOT RE 2
p-phenylenediamine	203-404-7	106-50-3	Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1
p-toluenesulphonic acid (containing a maximum of 5 % H2SO4);p-toluenesulphonic acid, (containing more than 5 % H2SO4)	203-180-0	104-15-4	Skin Corr. 1B
p-toluenesulphonic acid (containing a maximum of 5 % H2SO4);p-toluenesulphonic acid, (containing more than 5 % H2SO4)	203-180-0	104-15-4	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
p-toluidine; 4-aminotoluene	203-403-1	106-49-0	Carc. 2; Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1
p-tolyl 4-chlorobenzoate UP 565	411-530-0	15024-10-9	Skin Sens. 1
p-xylene	203-396-5	106-42-3	Flam. Liq. 3; Acute Tox. 4; Skin Irrit. 2
paraquat dichloride;1,1-dimethyl-4,4'-bipyridinium dichloride	217-615-7	1910-42-5	Acute Tox. 2; Acute Tox. 3; STOT RE 1; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
pebulate (ISO); N-butyl-N-ethyl-S-propylthiocarbamate	214-215-4	1114-71-2	Acute Tox. 4
pentaerythritol, dipentaerythritol, fatty acids, C6-10, mixed esters with adipic acid, heptanoic acid and isostearic acid	426-590-3	187412-41-5	Skin Sens. 1
pentane	203-692-4	109-66-0	Flam. Liq. 2; Asp. Tox. 1; STOT SE 3
pentane-2,4-dione; acetylacetone	204-634-0	123-54-6	Flam. Liq. 3; Acute Tox. 4
pentasodium (carboxylatomethyl)iminobis(ethylenenitrilo)tetraacetate	205-391-3	140-01-2	Repr. 1B; Acute Tox. 4; STOT RE 2
pentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate REACTIVE NAVY BLUE 9411; SUMIFIX SUPRA MARINE BNF GRANULES	423-790-2	1379676-74-0	Eye Dam. 1; Skin Sens. 1
pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate	436-920-8	172399-10-9	Eye Dam. 1
pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III) OLIVE-GREEN JB 1170	419-210-2	178452-71-6	Eye Dam. 1
penthachloronaphthalene	215-320-8	1321-64-8	Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2
perboric acid (H3BO2(O2)), monosodium salt trihydrate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid (H3BO2(O2)), monosodium salt, trihydrate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	603-902-8	13517-20-9	Repr. 1B; STOT SE 3; Eye Dam. 1
perboric acid (H3BO2(O2)), monosodium salt trihydrate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid (H3BO2(O2)), monosodium salt, trihydrate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	603-902-8	13517-20-9	Repr. 1B; Acute Tox. 4; STOT SE 3; Eye Dam. 1
perboric acid (HBO(O2)), sodium salt, monohydrate; sodium peroxoborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid (HBO(O2)), sodium salt, monohydrate; sodium peroxoborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	600-419-4	10332-33-9	Ox. Sol. 3; Repr. 1B; Acute Tox. 4; STOT SE 3; Eye Dam. 1
perboric acid (HBO(O2)), sodium salt, monohydrate; sodium peroxoborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid (HBO(O2)), sodium salt, monohydrate; sodium peroxoborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	600-419-4	10332-33-9	Ox. Sol. 3; Repr. 1B; Acute Tox. 3; Acute Tox. 4; STOT SE 3; Eye Dam. 1
perboric acid (HBO(O2)), sodium salt, tetrahydrate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid (HBO(O2)), sodium salt, tetrahydrate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	600-611-8	10486-00-7	Repr. 1B; Acute Tox. 4; STOT SE 3; Eye Dam. 1
perboric acid (HBO(O2)), sodium salt, tetrahydrate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid (HBO(O2)), sodium salt, tetrahydrate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	600-611-8	10486-00-7	Repr. 1B; STOT SE 3; Eye Dam. 1
perboric acid, sodium salt, monohydrate; sodium peroxoborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt, monohydrate; sodium peroxoborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt, tetrahydrate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt, tetrahydrate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt; sodium peroxoborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt; sodium peroxoborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	234-390-0	11138-47-9	Ox. Sol. 3; Repr. 1B; Acute Tox. 3; Acute Tox. 4; STOT SE 3; Eye Dam. 1
perboric acid, sodium salt, monohydrate; sodium peroxoborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt, monohydrate; sodium peroxoborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt, tetrahydrate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt, tetrahydrate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt; sodium peroxoborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt; sodium peroxoborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	234-390-0	11138-47-9	Repr. 1B; STOT SE 3; Eye Dam. 1
perboric acid, sodium salt, monohydrate; sodium peroxoborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt, monohydrate; sodium peroxoborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt, tetrahydrate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt, tetrahydrate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt; sodium peroxoborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt; sodium peroxoborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	234-390-0	11138-47-9	Ox. Sol. 3; Repr. 1B; Acute Tox. 4; STOT SE 3; Eye Dam. 1
perboric acid, sodium salt, monohydrate; sodium peroxoborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt, monohydrate; sodium peroxoborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt, tetrahydrate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt, tetrahydrate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt; sodium peroxoborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt; sodium peroxoborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	234-390-0	11138-47-9	Ox. Sol. 3; Repr. 1B; Acute Tox. 4; STOT SE 3; Eye Dam. 1
perboric acid, sodium salt, monohydrate; sodium peroxoborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt, monohydrate; sodium peroxoborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt, tetrahydrate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt, tetrahydrate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt; sodium peroxoborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt; sodium peroxoborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	234-390-0	11138-47-9	Ox. Sol. 3; Repr. 1B; Acute Tox. 3; Acute Tox. 4; STOT SE 3; Eye Dam. 1
perboric acid, sodium salt, monohydrate; sodium peroxoborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt, monohydrate; sodium peroxoborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt, tetrahydrate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt, tetrahydrate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt; sodium peroxoborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt; sodium peroxoborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	234-390-0	11138-47-9	Repr. 1B; Acute Tox. 4; STOT SE 3; Eye Dam. 1
perfluorooctane sulfonic acid; heptadecafluorooctane-1-sulfonic acid	217-179-8	1763-23-1	Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact.
pethoxamide (ISO); 2-chloro-N-(2-ethoxyethyl)-N-(2-methyl-1-phenylprop-1enyl)acetamide	600-765-6	106700-29-2	Acute Tox. 4; Skin Sens. 1
Petrolatum (petroleum), clay-treated; Petrolatum [A complex combination of hydrocarbons obtained by treatment of petrolatum with bleaching earth for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of greater than C25.] A complex combination of hydrocarbons obtained by treatment of petrolatum with bleaching earth for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of greater than C25.	309-706-6	100684-33-1	Carc. 1B
Phenanthrene, distn. residues; Heavy Anthracene Oi Redistillate [Residue from the distillation of crude phenanthrene boiling in the approximate range of 340 °C to 420 °C (644°F to 788°F). It consists predominantly of phenanthrene, anthracene and carbazole.] Residue from the distillation of crude phenanthrene boiling in the approximate range of 340°C to 420°C (644°F to 788°F). It consists predominantly of phenanthrene, anthracene and carbazole.	310-169-5	122070-78-4	Carc. 1B
phenol, 2-dodecyl-, branched	701-105-0	1801269-80-6	Repr. 1B; Skin Corr. 1C; Eye Dam. 1
phenol, 3-dodecyl-, branched	701-107-1	1801269-77-1	Repr. 1B; Skin Corr. 1C; Eye Dam. 1
phenol, dodecyl-, branched	310-154-3	121158-58-5	Repr. 1B; Skin Corr. 1C; Eye Dam. 1
phenol; carbolic acid; monohydroxybenzene; phenylalcohol	203-632-7	108-95-2	Muta. 2; Acute Tox. 3; STOT RE 2; Skin Corr. 1B
phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide CGI 819	423-340-5	162881-26-7	Skin Sens. 1A
phenyl glycidyl ether; 2,3-epoxypropyl phenyl ether;1,2-epoxy-3-phenoxypropane	204-557-2	122-60-1	Carc. 1B; Muta. 2; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Skin Sens. 1
phenylhydrazine	202-873-5	100-63-0	Carc. 1B; Muta. 2; Acute Tox. 3; STOT RE 1; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
phenylmercury hydroxide	202-866-7	100-57-2	Acute Tox. 3; STOT RE 1; Skin Corr. 1B
phosphamidon (ISO); 2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate	236-116-5	13171-21-6	Muta. 2; Acute Tox. 2; Acute Tox. 3
phosphonic acid	237-066-7	13598-36-2	Acute Tox. 4; Skin Corr. 1A
phosphoric acid, calcium nickel salt	-	17169-61-8	Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
phosphorous acid	233-663-1	10294-56-1	Acute Tox. 4; Skin Corr. 1A
phosphorus pentachloride	233-060-3	10026-13-8	Acute Tox. 2; Acute Tox. 4; STOT RE 2; Skin Corr. 1B
phosphorus pentoxide	215-236-1	1314-56-3	Skin Corr. 1A
phosphoryl trichloride	233-046-7	10025-87-3	Acute Tox. 2; STOT RE 1; Acute Tox. 4; Skin Corr. 1A
phoxim (ISO); α-(diethoxyphosphinothioylimino) phenylacetonitrile	238-887-3	14816-18-3	Repr. 2; Acute Tox. 4; Skin Sens. 1
picolinafen (ISO); N-(4-fluorophenyl)-6-[3-(trifluoromethyl)phenoxy] pyridine-2-carboxamide; 4′-fluoro-6-[(α,α,α-trifluoro-m-tolyl) oxy]picolinanilide	604-030-0	137641-05-5	STOT RE 2
piperazine [liquid];piperazine [solid]	203-808-3	110-85-0	Repr. 2; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1
piperazine [liquid];piperazine [solid]	203-808-3	110-85-0	Repr. 2; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1
piperazine dihydrochloride	205-551-2	142-64-3	Repr. 2; Eye Irrit. 2; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1

Showing 1,701 - 1,800 of 4,691 results.

Export search results to:

EU-SAFETY_HEALTH_WORK-PREAMBLE

EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 02 May 2024. Database contains 4691 unique substances/entries.

Footer Nav Items